EGFR and non-small cell lung carcinoma: A literature search summarized in Table S7 shows that resistance to EGFR-Tyrosine kinase-inhibitors (EGFR-TKI) in SCLC occurs without any of the known somatic mutations in EGFR responsible for acquired EGFR-TKI resistance observed in NSCLC.